“…8,21,22 The role of neoadjuvant or adjuvant therapy is still unclear, 4 and statistical evidence of any benefit from radiation therapy and chemotherapy in reducing recurrences is still lacking. 6,23,24 Several malignancies of different origin may extend to the infrahepatic IVC, including lymphoma, renal cell carcinoma, Wilms tumor, adrenal tumors, hepatic carcinoma, retroperitoneal metastatic lymph nodes, and different retroperitoneal sarcomas. 1,9,[25][26][27][28][29] Among all of them, leiomyosarcoma is associated with good survival despite its vascular origin and emanation from a potentially major conduit for metastatic dissemination.…”